← Back to Search

Device

Venus Bliss for Adipose Tissue Atrophy

N/A
Waitlist Available
Research Sponsored by Venus Concept
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a non-surgical method using a special laser, electromagnetic waves, and a suction device with radio waves to reduce belly and side fat. It targets people looking for non-invasive fat reduction. The laser heats and destroys fat cells, while the other devices help tone muscles and break down fat.

Eligible Conditions
  • Adipose Tissue Atrophy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Aesthetic Appearance From Baseline
Secondary study objectives
Change in Fat Thickness
Subject Satisfaction: 5-Point Likert Subject Satisfaction Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Subject treatment groupExperimental Treatment1 Intervention
Treatment group receiving 3 diode treatments and 3 RF/PEMF treatments at Week 0, 8 and 16 with a follow-up at Week 24.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Venus Bliss
2019
N/A
~60

Find a Location

Who is running the clinical trial?

Venus ConceptLead Sponsor
34 Previous Clinical Trials
1,285 Total Patients Enrolled
1 Trials studying Adipose Tissue Atrophy
12 Patients Enrolled for Adipose Tissue Atrophy
Yoni Iger, PhDStudy DirectorVenus Concept LTD
2 Previous Clinical Trials
58 Total Patients Enrolled
~6 spots leftby Nov 2025